The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs

Overview of attention for article published in Arthritis Research & Therapy, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,976 followers.

What is the impact of biologic therapies on the development of malignancies in early #rheumatoid #arthritis patients? Study says: https://t.co/92WNOqEobF https://t.co/pUUnCcydcC

RT @rheumatologymy: Biologic use associated with a lower risk of malignancy in early RA. #Cancer #RA https://t.co/G62l98a1ck

Biologic use associated with a lower risk of malignancy in early RA. #Cancer #RA https://t.co/G62l98a1ck

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.